Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Nfl Biosciences SAS banner

Nfl Biosciences SAS
F:82F

Watchlist Manager
Nfl Biosciences SAS Logo
Nfl Biosciences SAS
F:82F
Watchlist
Price: 0.835 EUR 3.21% Market Closed
Market Cap: €8.1m
Write Note Create Alert Ask AI

Wall St Price Targets

82F Price Targets Summary
Nfl Biosciences SAS

Wall Street analysts forecast 82F stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 82F is 3.457 EUR with a low forecast of 2.684 EUR and a high forecast of 4.732 EUR.

82F Lowest Forecast
Wall Street Target
€2.684
221% Upside
82F Average Forecast
Wall Street Target
€3.457
314% Upside
82F Highest Forecast
Wall Street Target
€4.732
467% Upside
Lowest Forecast
Price Target
2.684 EUR
221% Upside
Average Forecast
Price Target
3.457 EUR
314% Upside
Highest Forecast
Price Target
4.732 EUR
467% Upside
Nfl Biosciences SAS Competitors:
Price Targets
CSGP
CoStar Group Inc
15% Upside
NEPHROPLUS
Nephrocare Health Services Ltd
23% Upside
D
DSS
Dss Inc
463% Upside
AMP
Amper SA
30% Upside
CSGP
CoStar Group Inc
15% Upside
NEPHROPLUS
Nephrocare Health Services Ltd
23% Upside
D
DSS
Dss Inc
463% Upside
AMP
Amper SA
30% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Nfl Biosciences SAS

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat

What are analyst estimates?

Continue 82F Research

Summary
82F intrinsic value, competitors valuation, and company profile.
DCF Valuation
82F stock valuation using Discount Cash Flow valuation method.
Relative Valuation
82F stock valuation using valuation multiples.
Wall St Estimates
82F price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
82F stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Nfl Biosciences SAS listings:
PAR • EUR
ALNFL
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 82F's stock price target?
Price Target
3.457 EUR

According to Wall Street analysts, the average 1-year price target for 82F is 3.457 EUR with a low forecast of 2.684 EUR and a high forecast of 4.732 EUR.

Back to Top
ALPHA SPREAD
Follow us
Join 355,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett